Search clinical trials for: Marginal Zone

Total 1864 results

Ruijin Hospital

Not yet recruiting

A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma

Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)

China
Sun Yat-sen University

Not yet recruiting

Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma (ROMA)

Marginal Zone Lymphoma(MZL)

China
SWOG Cancer Research Network
National Cancer Institute (NCI)

Not yet recruiting

Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment

Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Lymphoma | Splenic Marginal Zone Lymphoma | Marginal Zone Lymphoma | Nodal Marginal Zone Lymphoma | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | Extranodal Marginal Zone Lymphoma | Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma

United States
Henan Cancer Hospital

Not yet recruiting

CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma

MZL

Search clinical trials for: Marginal Zone

This is a preview